LEADIANT BIOSCIENCES, INC.
ROCKVILLE, MD

Leadiant Biosciences, Inc., formerly known as Sigma-Tau Rare Disease, is a globally recognized research-based pharmaceutical company. With a mission rooted in rare dedication, the organization strives to deliver effective therapies for patients suffering from rare diseases. It collaborates with global patient communities, physicians, and researchers aiming to be a beacon of hope by overcoming significant medical challenges. The company invests substantial resources into the development, registration, and commercialization of innovative pharmaceutical products that significantly improve patients' quality of life while ensuring a fair return on investment to its shareholders. As a private entity, Leadiant Biosciences prioritizes patient service in all its endeavors. The corporate structure of Leadiant Biosciences includes various operational entities under the holding company Leadiant Biosciences S.p.A., which oversees strategic and financial directives globally while providing essential legal, financial, and administrative services. The leadership team spearheaded by Dr. Brughera, CEO and Global Head of Rare Disease, comprises seasoned executives experienced in multifaceted aspects of pharmaceuticals with special expertise in rare disease products. Dr. Brughera brings a wealth of knowledge from his extensive background in oncology and R&D, having held significant roles at major industry players like Pfizer, Inc. Complementing the leadership team are Mr. Deveque as Chief Financial Officer, Ms. Laureti as General Counsel, and Dr. Noseda as Chief Scientific Officer, each bringing unique expertise to enhance corporate strategy and scientific innovation. Listed under status Florida.Models.Dos.FloridaCompanyStatus, the corporation established on March 8, 2017, by filing number F17000001102 in Leon County is a FORP company. Its mailing address is located at 530 Gaither Rd., Rockville, MD, with operational and contact numbers across various regions. Leadiant Biosciences maintains an active online presence via its official website (leadiantbiosciences.com), fostering transparency through annual reports, the latest being recorded on January 8, 2025. The FEI number associated with the company is 880485370.